HIV / AIDS in the News

CRISPR Targeted HIV Inside Living Humans for the First Time - Yahoo

 

UMass professor working to make at-home HIV tests accessible - franklincountynow.com

 

Russian Strike Destroyed Millions of H.I.V. Prevention Supplies in Ukraine - The New York Times

 

Risk of death 21% lower in patients with HIV-related fungal disease who were given combination drug treatment - Medical Xpress

 

Merck & Co., Inc. (MRK) Discusses HIV Program Updates and Phase III Data from International AIDS Conference - Slideshow (NYSE:MRK) 2026-08-03 - Seeking Alpha

 

MSF Belgium urges governments to secure affordable access to HIV prevention shot - euractiv.com

 

AIDS 2026: HIV cure strategies, with or without latency reversal - bioworld.com

 

TIL Cell Therapy in HIV Positive Patient With Metastatic Melanoma: Case Report - CancerNetwork

 

Once-Weekly Pill Could Revolutionize HIV Treatment - usnews.com

 

THEATER Wrenching but urgent political drama follows two women with HIV along ‘Continuum’ - Windy City Times

 

Once-Weekly Pill Could Revolutionize HIV Treatment - HealthDay

 

HIV funding cuts risk 'unravelling decades of progress', experts warn - euronews.com

 

Key Populations Under Threat: A Central Theme at AIDS 2026 - HHR Journal

 

UMass Amherst professor gets $1.3M grant to develop more accurate at-home HIV test - Greenfield Recorder

 

UCSF study finds patient care affected by HIV/AIDS funding disruption - San Francisco Examiner

 

Results of the CAPRISA 012c clinical trial of a combination of two bnAbs to prevent HIV infection in young women in southern Africa announced at AIDS 2026 - European AIDS Treatment Group

 

[AIDS 2026] Infectious Disease Special Edition: Long-acting Cabenuva shows comparable real-world effectiveness to daily Biktarvy - European AIDS Treatment Group

 

[AIDS 2026] MedPage Today: Long-acting lenacapavir still delivered effective HIV PrEP after a year - European AIDS Treatment Group

 

Caribbean HIV Infections Drop 30% - St Vincent Times

 

[AIDS 2026] Managed Healthcare Executive: Community-led chemsex harm reduction programs boost HIV retention in South Africa, other countries - European AIDS Treatment Group

 

International AIDS Society: Takeaways from AIDS 2026 - European AIDS Treatment Group

 

[AIDS 2026] HIV Justice Network: New analysis finds HIV travel restrictions are shifting from border bans to hidden migration barriers as global progress stalls - European AIDS Treatment Group

 

[AIDS 2026] HIV Justice Network: New global Guidance on HIV decriminalisation launched at AIDS 2026 - European AIDS Treatment Group

 

[AIDS 2026] aidsmap: Alternative first-line HIV regimen limits excess weight gain - European AIDS Treatment Group

 

[AIDS 2026] aidsmap: Two more people cured of HIV after stem cell transplants, offering more clues to long-term remission - European AIDS Treatment Group

 

Alternative first-line HIV regimen limits excess weight gain - Aidsmap

 

[AIDS 2026] aidsmap: New US HIV agreements leave civil society and key populations on the sidelines - European AIDS Treatment Group

 

Long-Acting Lenacapavir Still Delivered Effective HIV PrEP After a Year - medpagetoday.com

 

New US HIV agreements leave civil society and key populations on the sidelines - Aidsmap

 

Fiji’s perfect HIV storm - Aidsmap